Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy
Related Posts
Musci RV, Johnson M, Morrow N, Crenshaw CD, Daniel MK, Peelor FF, Miller BF, Pham J, Hevener AL, Wanagat J. Measurement of Skeletal Muscle Mitochondrial[...]
Sample K, Venkatappa MM, Koo YD, Foulks Z, Ng V, Shaffer M, Lietsch ML, Adamcakova-Dodd A, Thorne PS, McCommis KS, Sannaningaiah D, Robertson RM, Exil[...]
Brown MJ, Turcu AF, Sam R, Kirschner LS, Hamidi O, Eren A, Ben-Shlomo A, Huang W, Bancos I, Hamrahian AH, Freeman MW. Hyperaldosteronism Remission after[...]